We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

126 hedge funds and large institutions have $90.6M invested in Bionano Genomics in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more call options, than puts

Call options by funds: $1.6M | Put options by funds: $749K

17% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 35

0% less ownership

Funds ownership: 0.05% → 0.04% (-0%)

12% less funds holding

Funds holding: 143 → 126 (-17)

48% less capital invested

Capital invested by funds: $176M → $90.6M (-$84.9M)

65% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 26

Holders
126
Holders Change
-17
Holders Change %
-11.89%
% of All Funds
2.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
41
Reduced
35
Closed
26
Calls
$1.6M
Puts
$749K
Net Calls
+$854K
Net Calls Change
-$1.57M

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$1.2M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$607K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$513K
4
ACS
Archford Capital Strategies
Illinois
+$455K
5
State Street
State Street
Massachusetts
+$394K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$2.1M
2
Millennium Management
Millennium Management
New York
-$1.71M
3
Goldman Sachs
Goldman Sachs
New York
-$632K
4
Morgan Stanley
Morgan Stanley
New York
-$387K
5
Group One Trading
Group One Trading
Illinois
-$299K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAG
101
Private Advisor Group
New Jersey
$11.6K -$888 -1 -6%
LWM
102
Laidlaw Wealth Management
New York
$11.1K – – –
MOS
103
MGO One Seven
Ohio
$11.1K – – –
Fidelity Investments
104
Fidelity Investments
Massachusetts
$6.58K -$20.4K -23 -70%
CG
105
Cutler Group
California
$6K -$888 -1 -9%
Nisa Investment Advisors
106
Nisa Investment Advisors
Missouri
$5K -$13.3K -15 -65%
TWC
107
TD Waterhouse Canada
Ontario, Canada
$4.92K – – –
BAM
108
Belpointe Asset Management
Nevada
$2.66K – – –
US Bancorp
109
US Bancorp
Minnesota
$2.41K – – –
AWM
110
AllSquare Wealth Management
New York
$2.22K – – –
TWA
111
TCI Wealth Advisors
Arizona
$2.22K – – –
SWM
112
Spire Wealth Management
Virginia
$2.13K – – –
AIP
113
Ahrens Investment Partners
Louisiana
$1.39K +$1.78K +2 New
LC
114
Lindbrook Capital
California
$1.35K +$1.78K +2 New
CQS
115
Credential Qtrade Securities
$1.13K – – –
AA
116
Ancora Advisors
Ohio
$1.11K – – –
CSWM
117
Cassady Schiller Wealth Management
Ohio
$1.11K – – –
TWD
118
True Wealth Design
Ohio
$1.05K – – –
National Bank of Canada
119
National Bank of Canada
Quebec, Canada
$881 – – –
IA
120
IFP Advisors
Florida
$874 – – –
Fifth Third Bancorp
121
Fifth Third Bancorp
Ohio
$794 – – –
PNC Financial Services Group
122
PNC Financial Services Group
Pennsylvania
$716 – – –
TF
123
TimeScale Financial
Massachusetts
$608 – – –
Northwestern Mutual Wealth Management
124
Northwestern Mutual Wealth Management
Wisconsin
$555 – – –
AF
125
Allworth Financial
California
$444 – – –
3 4
5
6 7

BNGO Hedge Fund Activity: Q1 2023 in Review

126 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q1 2023, worth a combined $90.6M — down 48% from $176M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of BNGO and 9 opened new positions — a net loss of 17 holders — while 35 trimmed existing stakes and 41 added.

The largest buyer was Nuveen, adding an estimated $1.2M. The largest seller was Citadel Advisors, cutting an estimated $2.1M.

  • 126 institutional investors held Bionano Genomics (BNGO) as of Q1 2023, down from 143 in Q4 2022.
  • Funds reported $90.6M of Bionano Genomics stock for Q1 2023, down 48% quarter-over-quarter.
  • 9 funds opened new Bionano Genomics positions in Q1 2023 and 26 closed out, a net change of -17 holders.
  • The largest Bionano Genomics buyer in Q1 2023 was Nuveen, an estimated $1.2M added.
  • The largest Bionano Genomics seller in Q1 2023 was Citadel Advisors, an estimated $2.1M sold.

Based on aggregated 13F filings for Q1 2023.